✦ LIBER ✦

Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6–9 and 10–13 years

✍ Scribed by Ruprecht Schmidt-Ott; Tino Schwarz; Rainer Haase; Helga Sander; Uta Walther; Marc Fourneau; Latt Htun-Myint; Roland Sänger; Volker Schuster

Book ID: 116960164
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 375 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2007.10.049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of immunogenicity and reactog

Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children aged 6–35 months

✍ Kim, Yun Kyung; Eun, Byung Wook; Kim, Nam Hee; Kang, Eun Kyeong; Lee, Byung Sub; 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 158 KB

Immunogenicity, reactogenicity, and safe

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial

✍ Tinoco, Juan Carlos; Pavia-Ruz, Noris; Cruz-Valdez, Aurelio; Aranza Doniz, Carlo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 603 KB

A randomized, double-blind trial to eval

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

✍ T.F. Schwarz; J. Flamaing; H.C. Rümke; J. Penzes; C. Juergens; A. Wenz; D. Jayaw 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Absence of cross-reactive antibodies to

Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months–9 years: a prospective study

✍ Jodie McVernon; Karen Laurie; Ian Barr; Anne Kelso; Maryanne Skeljo; Terry Nolan 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 101 KB

Safety and immunogenicity of ASO3Badjuva

Safety and immunogenicity of ASO3Badjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

✍ UKPVG H1N1 Influenza Vaccine Collaboration 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 299 KB

Safety and immunogenicity of 2010–2011 H

Safety and immunogenicity of 2010–2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12–59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: A PHAC/CIHR Influenza Research Network (PCIRN) study

✍ Joanne M. Langley; David W. Scheifele; Caroline Quach; Otto G. Vanderkooi; Brian 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 213 KB